BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11178978)

  • 1. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
    Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of residue F552 in domain III of the protective antigen in the biological activity of anthrax lethal toxin.
    Khanna H; Gupta PK; Singh A; Chandra R; Singh Y
    Biol Chem; 2001 Jun; 382(6):941-6. PubMed ID: 11501759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of anthrax toxin protective antigen from Escherichia coli.
    Sharma M; Swain PK; Chopra AP; Chaudhary VK; Singh Y
    Protein Expr Purif; 1996 Feb; 7(1):33-8. PubMed ID: 9172780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
    Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
    Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore.
    Zhang S; Cunningham K; Collier RJ
    Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pH on stability of anthrax lethal factor: correlation between denaturation and activity.
    Gupta P; Singh S; Tiwari A; Bhat R; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jun; 284(3):568-73. PubMed ID: 11396937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen.
    Ahuja N; Kumar P; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Sep; 287(2):542-9. PubMed ID: 11554763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a fourier-transform infrared spectroscopy approach.
    Wang XM; Mock M; Ruysschaert JM; Cabiaux V
    Biochemistry; 1996 Nov; 35(47):14939-46. PubMed ID: 8942659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of anthrax lethal factor microinjected into macrophage cells through Sendai virus envelopes.
    Swain PK; Sarkar NK; Sharma M; Goel S; Singh RP; Singh Y
    Indian J Biochem Biophys; 1997; 34(1-2):186-91. PubMed ID: 9343949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
    Young JA; Collier RJ
    Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax toxins.
    Mourez M
    Rev Physiol Biochem Pharmacol; 2004; 152():135-64. PubMed ID: 15549606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the anthrax protective antigen binding site on the lethal and edema factors.
    Lacy DB; Mourez M; Fouassier A; Collier RJ
    J Biol Chem; 2002 Jan; 277(4):3006-10. PubMed ID: 11714723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.